Results 201 to 210 of about 1,191,682 (356)

Atypical type VI Osteogenesis Imperfecta mouse models the intersection of IFITM5 and SERPINF1 pathways in patients

open access: yesBone Reports, 2021
Gali Guterman-Ram   +7 more
doaj   +1 more source

Targeting VGLL4 maintains extracellular matrix homeostasis and mitigates osteoarthritis in a preclinical model. [PDF]

open access: yesNat Commun
Suo J   +17 more
europepmc   +1 more source

Extracellular matrix microfibrils are composed of core proteins coated with fibronectin.

open access: bronze, 1985
Elissa J. Schwartz   +3 more
openalex   +1 more source

Motor nerve regulates muscle extracellular matrix proteoglycan expression [PDF]

open access: hybrid, 1990
Ricardo Fadić   +2 more
openalex   +1 more source

Plasma‐Treated Hydrogel for Combined RONS and Chemotherapy Delivery: A Proof‐of‐Concept In Ovo

open access: yesAdvanced Functional Materials, EarlyView.
This study explores plasma‐treated hydrogels (PTH) as a new way to deliver both reactive oxygen and nitrogen species and chemotherapy (Doxorubicin) directly to tumors. In ovo tests show effects after a single dose, especially in osteosarcoma tumors. Tumor weight decrease, and a resistance‐related protein is reduced.
Milica Živanić   +9 more
wiley   +1 more source

Precise Quantification of Angiogenesis in 3D Biomaterials Using in Vitro CAM Models: Enhancing 3Rs in Research and Minimizing in Vivo Dependency

open access: yesAdvanced Functional Materials, EarlyView.
The study develops elastin–fibrin scaffolds and evaluates angiogenesis using the chorioallantoic membrane (CAM) model. Advanced imaging with confocal microscopy and Indocyanine Green dye enables precise 3D quantification of vascular networks. Findings demonstrate superior microvessel visualization compared to micro‐CT using Microfil and Optiray 350 ...
Ece Melis Er   +8 more
wiley   +1 more source

AI-driven discovery of novel extracellular matrix biomarkers in pelvic organ prolapse. [PDF]

open access: yesPLoS Comput Biol
Mi Y   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy